REFERENCES
- DeBaun MR, Vichinsky E. Hemoglobinopathies. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: Saunders Elsevier; 2007:2025–2038.
- Arcasoy A, Cavdar AO. Thalassemia incidence in Turkey. In: M Aksoy, ed. Proceedings of the thalassemia symposium of medical research group. Ankara: Scientific and Technical Research Council of Turkiye; 1982:3–19.
- Borgna-Pignatti C, Rugolotto S, De Stefeno P, . Survival and disease complications in thalassemia major. Ann N Y Acad Sci. 1998;850:227–231.
- Farmakis D, Giakomis A, Polymeropolus E, Aessopos A. Pathogenetic aspects of immune deficiency associated with beta-thalassemia. Med Sci Monit. 2003;9:RA19–RA22.
- Dwyer J, Wood C, McNamara J, . Abnormalities in the immune system of children with beta-thalassemia major. Clin Exp Immunol. 1987;68:621–629.
- Khalifa AS, Maged Z, Khalil R, . T-cell function in infants and children with beta-thalassemia. Acta Haematol. 1988;79:153–156.
- Ezer U, Gülderen F, Culha VK, . Immunological status of thalassemia syndrome. Pediatr Hematol Oncol. 2002;19:51–58.
- Dua D, Choudhury M, Prakash K. Altered T and B lymphocytes in multitransfused patients of thalassemia major. Indian Pediatr. 1993;30:893–896.
- Sinniah D, Yadav M. Elevated IgG and decreased complement C3 and factor B in β-thalassemia major. Acta Paediatr Scand. 1981;70:547–550.
- Sen L, Goicoa MA, Nualart PJ, . Immunologic studies in thalassemia major. Medicina (Bueno Aires). 1989;49:131–134.
- Walker EM Jr, Walker SM. Effects of iron overload on the immune system. Ann Clin Lab Sci. 2000;30:354–365.
- Rohav G, Volach V, Shapiro M, . Severe infections in thalassaemic patients: prevelance and predisposing factors. Br J Haematol. 2006;133:667–674.
- Consolini R, Calleri A, Legitimo A, Massei F. Immunological evaluation of patients with beta-thalassemia major. Acta Haematol. 2001;105:7–12.
- Wonke B. Clinical management of beta-thalassemia major. Semin Hematol. 2001;38:350–359.
- Wanachiwanawin W, Siripanyaphinyo U, Fucharoen S, . Activation of monocytes for the immune clearance of red cells in beta zero-thalassaemia/HbE. Br J Haematol. 1993;85:773–777.
- Corthay A. How do regulator T cells work? Scand J Immunol. 2009;70:326–336.
- Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531–562.
- Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol. 2003;15:430–435.
- Fehervari Z, Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest. 2004;9:1209–1217.
- Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–1061.
- Lau KM, Cheng SH, Lo KW, . Increase in circulating Foxp3+CD4+CD25high regulatory T cells in nasopharyngeal carcinoma patients. Br J Cancer. 2007;96:617–622.
- Musumeci S, Schiliro G, Romeo MA, . Lymphocyte changes in β-thalassaemia major. Arch Dis Child. 1979;54:954–957.
- Pattanapanyasat K, Thepthai C, Lamchiagdhase P, . Lymphocyte subsets and specific T-cell immune response in thalassemia. Cytometry. 2000;42:11–17.
- Akbar AN, Giardina PJ, Hilgartner MW, Grady RW. Immunological abnormalities in thalassaemia major. I. A transfusion-related increase in circulating cytoplasmic immunoglobulin-positie cells. Clin Exp Immunol. 1985;62:397–404.
- Del Vecchio GC, Schettini F, Piacente L, . Effects of deferiprone on immune status and cytokine pattern in thalassemia major. Acta Haematol. 2002;108:144–149.
- Odeberg J, Soderberg-Naucler C. Reduced expression of HLA class II molecules and interleukin-10 and transforming growth factor B1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures. J Virol. 2001;75:5174–5181.
- Ikinciogullari A, Kendirli T, Dogu F, . Peripheral blood lymphocyte subsets in healthy Turkish children. Turk J Pediatr. 2004;46:125–130.
- Fontenot JD, Rasmussen JP, Williams LM, . Regulatory T cell lineage specification by the fork-head transcription factor foxp3. Immunity. 2005;22:329–341.
- Kyriakou DS, Alexandrakis MG, Kyriakou E, . Activated peripheral blood and endothelial cells in thalasssemia patients. Ann Hematol. 2001;80:577–583.
- Gharagozloo M, Karimi M, Amirghofran Z. Double-faced cell-mediated immunity in β-thalassemia major: stimulated phenotype versus suppressed activity. Ann Hematol. 2009;88:21–27.